Autopsy report · NCT01664273

Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer

“Production of the IMP (plasmid AMEP) has been terminated by the supplier (BioAlliance Pharma)”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 10 months before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Copenhagen University Hospital at Herlev

Sponsor type

University, hospital or other

Conditions

Metastatic Malignant Neoplasm

Interventions

Plasmid AMEP

Participants

7

Sites

1

Countries

Denmark

Trials that died the same way

• HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
  “Company stopped development and production of one of the IMP's.” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.